MedPath

Superiority of Para-thyroid hormone Therapy for Healing of bone fracture

Not Applicable
Conditions
lumbar spinal stensis cervical spondylotic myelopathy
Registration Number
JPRN-UMIN000019566
Lead Sponsor
Department of Orthopedic Surgery, Osaka City University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1: patient who already taken the medicine for porosis before surgery. 2: patient who is tought to be hard to continue the study. 3: patient with OPLL or OYL 4: patient who is as an outpatieents of dentist 5: patient who has high risk of osteosarcoma 6: patient with hypercalcemia 7: patient with malignant tumor 8: patient with metabolic bone disease 9: patient who is taking digitalis. 10: patient with allergy for bisphosphonat or teriparatide 11: patient whose renal dysfunction 12: pregnant

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recovery rate of JOA scores at 24 year postoperatively
Secondary Outcome Measures
NameTimeMethod
JOACMEQ JOABPEQ SF-36 VAS bone union rate screw loosenisng rate BMD new fracture rate
© Copyright 2025. All Rights Reserved by MedPath